Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients

Annals of Nutrition and Metabolism

Volumn 58, Issue 3, 2011, Pages 197-202

  Kooshki, A ^a   Taleban, F A ^b   Tabibi, H ^b,c   Hedayati, M ^b  

^a SABZEVAR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c National Nutrition and Food Technology Research Institute Tehran   (Iran)

Author keywords

Hemodialysis; Marine omega 3 fatty acids; Oxidative stress; Systemic inflammation; Vascular inflammation

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MALONALDEHYDE; OMEGA 3 FATTY ACID; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULITIS;

ADULT; AGED; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; E-SELECTIN; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; P-SELECTIN; RENAL DIALYSIS; RISK FACTORS; SERUM; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR DISEASES; YOUNG ADULT;

EID: 79960224686     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000329727     Document Type: Article

References (36)

1. Singh AK, Brenner BM: Dialysis in the treatment of renal failure; in Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds): Harrison's Principles of Internal Medicine, ed 16. New York, McGraw- Hill, 2005, pp 1663-1667.
2. Jungers P, Nguyen Khoa T, Massy ZA, Zingraff J, Labrunie M, Descamps-Latscha B, Man NK: Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patient: A multicentric study in the Ile de France district. Nephrol Dial Transplant 1999; 14: 898-902. (Pubitemid 29155144)
3. Stenvinkel P: Inflammation in end-stage renal failure: Could it be treated? Nephrol Dial Transplant 2002; 17(suppl 8):33-38. (Pubitemid 34918877)
4. Stenvinkel P, Yeun JY: Role of inflammation in malnutrition and atherosclerosis in chronic renal failure; in Kopple JD, Massry SG (eds): Kopple & Massry's Nutritional Management of Renal Disease, ed 2. Philadelphia, Lippincott, Williams & Wilkins, 2004, pp 199-212.
5. Rabb H, Calderon E, Bittle PA, Ramirez G: Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule- 1 in hemodialysis patients. Am J Kidney Dis 1996; 27: 239-243. (Pubitemid 26055137)
6. Musial K, Zwolinska D, Polak-Jonkisz D, Berny U, Szprynger K, Szczepanska M: Soluble adhesion molecules in children and young adults on chronic hemodialysis. Pediatr Nephrol 2004; 19: 332-336. (Pubitemid 38313020)
7. Musial K, Zwolinska D, Berny U, Polak- Jonkisz D, Szprynger K, Szczepanska M: Soluble adhesion molecules in children and young adults with chronic renal failure treated conservatively (abstract). Rocz Akad Med Bialymst 2004; 49: 209-212.
8. Musial K, Zwolinska D, Polak-Jonkisz D, Berny U, Szprynger K, Szczepanska M: Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol 2005; 20: 52-55. (Pubitemid 40057854)
9. Bolton CH, Downs LG, Victory JGG, Dwight JF, Tomson CRV, Mackness MI, Pinkney JH: Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1189-1197. (Pubitemid 32547374)
10. Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN: Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients: A pilot study. Nephrol Dial Transplant 2007; 22: 3561-3567. (Pubitemid 350212489)
11. Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D: Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients. Ren Fail 2007; 29: 321-329. (Pubitemid 46752347)
12. Madsen T, Schmidt EB, Christensen JH: The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr 2007; 17: 258-263. (Pubitemid 46936230)
13. Fiedler R, Mall M, Wand C, Osten B: Shortterm administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr 2005; 15: 253-256.
14. Sampson MJ, Davies IR, Brown JC, Morgan V, Richardson T, James AJ, Sampson AP, Hughes DA: N-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in type 2 diabetes mellitus. Diabet Med 2001; 18: 51-58. (Pubitemid 32158109)
15. Kang M, Ragan BG, Park JH: Issues in outcomes research: An overview of randomization techniques for clinical trials. J Athl Train 2008; 43: 215-221. (Pubitemid 351508038)
16. Daugirdas JT, Stone JCV: Physiologic principles and urea kinetic modeling; in Daugirdas JT, Blake PG, Ing TS (eds): Handbook of Dialysis, ed 3. Philadelphia, Lippincott, Williams & Wilkins, 2001, pp 15-4.
17. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J: Circulating cell adheshion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-1342. (Pubitemid 32880144)
18. Tedgui A: The role of inflammation in atherothrombosis: Implications for clinical practice. Vasc Med 2005; 10: 45-53. (Pubitemid 40667586)
19. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O: Elevated serum levels of soluble adhesion molecules predict death in predialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000; 15: 1624-1630.
20. Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, Arnesen H: Influence of long term intervention with dietary counseling, long-chain n-3 fatty acid supplements or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr 2005; 81: 583-589.
21. Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM: Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arterioscler Thromb Vasc Biol 1998; 18: 723-731. (Pubitemid 28267651)
22. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, Beilin LJ: Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 2003; 166: 85-93. (Pubitemid 35449604)
23. Lee KW, Blann AD, Lip GY: Effects of omega- 3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction. Thromb Res 2006; 118: 305-312. (Pubitemid 44067196)
24. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, Willett WC, Hu FB: Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004; 134: 1806-1811. (Pubitemid 38886573)
25. Chen W, Esselman WJ, Jump DB, Busik JV: Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2005; 46: 4342-4347. (Pubitemid 44264641)
26. Jacobs P, Glorieux G, Vanholder R: Interleukin/ cytokine profiles in haemodialysis and in continuous peritoneal dialysis. Nephrol Dial Transplant 2004; 19(suppl 5):v41-v45. (Pubitemid 39214199)
27. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ: Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003; 35: 772-781. (Pubitemid 37329480)
28. Vega-López S, Kaul N, Devaraj S, Cai RY, German B, Jialal I: Supplementation with omega3 polyunsaturated fatty acids and allrac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004; 53: 236-240. (Pubitemid 38168897)
29. Kelley DS, Siegel D, Fedor DM, Adkins Y, Mackey BE: DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009; 139: 495-501.
30. Moreira AC, Gaspar A, Serra MA, Simões J, Lopes da Cruz J, Amaral TF: Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis. J Ren Nutr 2007; 17: 205-213. (Pubitemid 46617298)
31. Tetta C, Biasiol S, Schiavon R, Inguaggiato P, David S, Panichi V, Wratten ML: An overview of haemodialysis and oxidant stress. Blood Purif 1999; 17: 118-126. (Pubitemid 29403569)
32. Canaud B, Cristol JP, Morena M, Leray- Moragues H, Bosc JY, Vaussenat F: Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif 1999; 17: 99-106. (Pubitemid 29403567)
33. Galli F, Ronco C: Oxidant stress in hemodialysis. Nephron 2000; 84: 1-5. (Pubitemid 30066135)
34. Bonanome A, Biasia F, De Luca M, Munaretto G, Biffanti S, Pradella M, Pagnan A: N-3 Fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr 1996; 63: 261-266.
35. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler RG, Tedesco M, Maccarrone M: N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int 2006; 69: 1450-1454.
36. Ando M, Sanaka T, Nihei H: Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol 1999; 10: 2177-2184. (Pubitemid 29453496)